Repression of rRNA gene transcription by endothelial SPEN deficiency normalizes tumor vasculature via nucleolar

Insights

Split end (SPEN), a transcription repressor, is crucial for blood vessel formation in tumors. Inhibiting SPEN normalizes tumor vasculature, repressing cancer growth and metastasis, offering a new therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Vascular Biology

Background:

  • Human cancers develop chaotic, dysfunctional tumor vasculature, hindering therapeutic efficacy.
  • Mechanisms driving tumor vasculature dysfunction remain largely unknown.

Purpose of the Study:

  • To elucidate the role of split end (SPEN) in endothelial cells (ECs) and its impact on angiogenesis.
  • To investigate SPEN's role in tumor vascularization and identify potential therapeutic targets.

Main Methods:

  • Investigated SPEN's function in ECs using knockdown and knockout models.
  • Analyzed the effects of SPEN deficiency on angiogenesis, p53 activation, and rRNA synthesis.
  • Examined SPEN expression in human cancer biopsies and its correlation with patient survival.
  • Utilized RNA polymerase I (RNPI) inhibitor CX-5461 and cisplatin in mouse cancer models.

Main Results:

  • SPEN deficiency in ECs attenuated proliferation and angiogenesis, linked to p53 activation via noncoding promoter RNA (pRNA).
  • Low endothelial SPEN levels in human cancers correlated with improved overall survival.
  • Endothelial SPEN deficiency repressed tumor growth and metastasis in mice by normalizing tumor vessels, dependent on p53.
  • RNPI inhibition with CX-5461 mimicked SPEN ablation effects, and combination therapy with cisplatin enhanced anti-tumor efficacy.

Conclusions:

  • SPEN is essential for angiogenesis by regulating rRNA gene transcription and ribosomal biogenesis.
  • Targeting RNPI offers a promising strategy for tumor vessel normalization therapy in cancer treatment.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K